Although adverse reactions to intravenous, intramuscular or subcutaneous injection of 0.9% benzyl alcohol are not known to occur in man, experimental studies of small volume parenteral preparations containing 0.9% benzyl alcohol in several species of animals have indicated that an estimated intravenous dose up to 30 mL may be safely given to an adult without toxic effects
Human Data In comparison with animal data, current human studies are still scarce
Most acute injuries show significant resolution
Symptoms include shortness of breath, muscle soreness, vomitin g , and diarrhea
In this regard, the following guidelines should be kept in mind: Ideal Storage Temperature for Longer Shelf-Life Once the vial containing bacteriostatic water for injection is opened, it is recommended to keep it stored at controlled room temperature for up to 28 days
For ghk-cu topical, the first practical step is to separate human evidence from preclinical or anecdotal claims